Overweight people tend to have worse cholesterol and higher uric acid levels — these might hurt the heart even if they don’t have diabetes or high blood pressure.
Claim Context
In middle-aged Thai adults with BMI ≥23 kg/m², excess body weight is associated with higher levels of low-density lipoprotein cholesterol, triglycerides, uric acid, and lower high-density lipoprotein cholesterol, which may contribute to cardiovascular risk independently of diabetes and hypertension.
“Participants with excess body weight... had higher levels of LDL-C, triglyceride and uric acid, but lower HDL-C... Elevated serum uric acid has been shown to be a predictor of coronary calcium deposition independent of conventional CV risk factors.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
That lowering LDL-C, triglycerides, or uric acid in overweight adults without T2DM/HT reduces subclinical atherosclerosis progression.
A 4-arm RCT of 1,200 adults with BMI ≥23, normal glucose and BP, randomized to: 1) statin, 2) omega-3, 3) allopurinol, 4) placebo for 3 years, with primary outcome of coronary calcium score change via CT.
Whether baseline lipid/uric acid levels predict CVEs in overweight adults without T2DM or HT over time.
A prospective cohort of 8,000 adults with BMI ≥23 and no T2DM/HT, followed for 15 years, analyzing time-to-CVE by quartiles of LDL-C, TG, uric acid, and HDL-C, adjusting for weight change.
Whether individuals with CVEs and BMI ≥23 have more severe lipid abnormalities than matched controls without CVEs.
A case-control study of 500 adults with CVEs and BMI ≥23, matched to 500 controls without CVEs, comparing fasting lipid profiles and serum uric acid levels.
The correlation between visceral fat mass and lipid/uric acid levels in overweight adults.
A cross-sectional analysis of 1,000 adults with BMI ≥23, measuring visceral adipose tissue via MRI and correlating with lipid and uric acid levels.
A consensus on the biological plausibility of dyslipidemia and hyperuricemia as direct mediators of CVD in obesity.
A systematic expert review by lipidologists and rheumatologists evaluating mechanistic studies on adipose-driven dyslipidemia and uric acid-induced endothelial dysfunction.